Emperion

Emperion Emerges as a Standalone Entity, Focusing on Medical Review Services After Split from Enlyte

WAYNE, PA — Emperion has officially completed its separation from Enlyte, taking over the Independent Medical Examination (IME), Peer Review, and Independent Review Organization (IRO) services. This transition, initiated in …

Emperion Emerges as a Standalone Entity, Focusing on Medical Review Services After Split from Enlyte Read More



Ocugen

Ocugen Advances in Pioneering Gene Therapy for Geographic Atrophy with DSMB Approval to Proceed to Medium Dose in Clinical Trial

MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focusing on discovering, developing, and commercializing transformative therapies to cure blindness diseases, announced a significant milestone in its Phase 1/2 …

Ocugen Advances in Pioneering Gene Therapy for Geographic Atrophy with DSMB Approval to Proceed to Medium Dose in Clinical Trial Read More